Pharmaceuticals – Market Institute

Articles

Sanders’ Transparent Attempt to Bully Drug Companies

In a recent turn of events, Senator Bernie Sanders has raised eyebrows by calling for the subpoena of two drug company CEOs, sparking both curiosity and concern. Market Institute President Charles Sauer’s new article in Townhall delves into Sanders’ unconventional tactics, questioning the wisdom of his confrontational approach to the Read more…

By admin, 11 months11 months ago

Articles

The Problem with Drug Price Controls

President Biden’s populist approach to healthcare reform, focusing on price controls, has stirred controversy in the pharmaceutical industry. A new article by Market Institute President Charles Sauer in The Hill highlights the potential consequences of this strategy, including drug shortages and stifled innovation. By exploring the lessons learned from Japan’s Read more…

By admin, 1 year1 year ago